Author

S. Kaech

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Daniels· 1 shared A. Iwasaki· 1 shared A. Kuhlmann· 1 shared B. E. Turk· 1 shared B. Miller· 1 shared C. Calderwood· 1 shared C. Perry· 1 shared C. Robles-Oteiza· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Daniels

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Setdb1-loss induces type-I interferons and immune clearance of melanoma

M. K. McGeary, W. Damsky, A. Daniels, E. Song, G. Micevic, C. Calderwood, H. J. Lou, S. Paradkar, S. Kaech, D. A. Calderwood, B. E. Turk, A. Iwasaki, M. W. Bosenberg

This study identifies Setdb1 loss as a driver of type-I interferon signaling and immune clearance of melanoma through ERV activation and CD8+ T-cell infiltration.

bioRxiv · May 23, 2023Cancer Biology

Illuminating histidine phosphorylation in the pancreatic tumor microenvironment

T. Hunter, G. Wahl, N. Lytle, K. E. DelGiorno, Y. Shi, S. Kaech, R. Naeem, N. Luhtala, M. Hollingsworth

The paper investigates phosphohistidine (pHis) pathway regulation in the mouse pancreatic tumor microenvironment using novel antibodies and identifies deregulated pHis signals and potential substrates.

bioRxiv · Sep 15, 2022 · PreprintCancer Biology

Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration ofinflammatory immune cells in EGFR mutant lung tumors

D. Ayeni, B. Miller, A. Kuhlmann, P.-C. Ho, C. Robles-Oteiza, M. Gaefele, S. Levy, F. de Miguel, C. Perry, T. Guan, D. Zelterman, R. Homer, Z. Liu, S. Kaech, K. Politi

The paper shows that erlotinib and oncogene withdrawal in EGFR mutant lung tumors increase infiltration of inflammatory immune cells, suggesting immunostimulatory effects of tumor regression.

bioRxiv · Jan 27, 2018Cancer Biology